Latest / CareTalk: Healthcare. Unfiltered.
The FDA is Taking a Big Risk on AI
Send us Fan Mail
The FDA is charging ahead with generative AI, claiming it can cut scientific review times from days to minutes. But is this innovation or recklessness?
In this episode of CareTalk, David Williams and John Driscoll debate whether the FDA’s rapid deployment of AI is a smart move or a potentially dangerous shortcut.
Stream our episode with FDA leader, Dr. Marty Makary, here.
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.